This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages without signing in

Trials of interferon beta-1a

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

Interferon beta-1a is produced in cultured mammalian cells and has the same aminoacid structure and carbohydrate side-chains as the human cytokine.

Two trials have been published using interferon beta-1a in relapsing-remitting multiple sclerosis:

  • the MSCRG study
  • the PRISMS study

Related pages

Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.